HeartFlow announces new chief operating officer

HeartFlow, the California-based health technology company focused on cardiac care, has named John Farquhar its chief operating officer (COO).

The news comes just weeks after HeartFlow announced its plans to merge with Longview Acquisition Corp. II and form a publicly traded company. Farquhar’s role as the company’s first COO will be to support the firm's vision as it continues to grow.

“I am excited to join an innovative, high-growth company with a compelling vision to change the paradigm for managing and treating heart disease,” Farquhar said in a prepared statement. “I look forward to working with the leadership team at HeartFlow to democratize access to this incredible technology.”

Farquhar has more than 20 years of experience in management roles. Most recently, he served as the vice president and general manager of Medtronic’s aortic business.

“We are thrilled to add an executive of John’s caliber and accomplishments to the HeartFlow leadership team,” John H. Stevens, MD, president, CEO and co-founder of HeartFlow, said in the same statement. “In his new role, he will lead and provide strategic oversight of our key operational areas to ensure excellence and disciplined growth as HeartFlow continues to transform the diagnosis and management of coronary artery disease.”

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.